The influence of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral grafts

Cell Transplantation

Volumn 4, Issue 1, 1995, Pages 141-154

  Freeman, Thomas B ^a   Sanberg, Paul R ^a,b   Nauert, G Michael ^c   Boss, Barbara D ^d   Spector, Dennis ^d   Olanow, C Warren ^e   Kordower, Jeffrey H ^f  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Department of Psychiatry University of South Florida ^*  (United States)

^d Woman's Center ^*  (United States)

^e MOUNT SINAI MEDICAL CENTER   (United States)

^f RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dopamine; Fetal; Nigra; Parkinson's disease; Transplant

Indexed keywords

AGE; ANIMAL EXPERIMENT; CELL TRANSPLANTATION; CELL VIABILITY; CONFERENCE PAPER; DOPAMINERGIC NERVE CELL; EMBRYO CELL; FEMALE; GRAFT SURVIVAL; HUMAN; HUMAN CELL; MESENCEPHALON; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RAT;

AGE FACTORS; ANIMAL; FEMALE; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; HUMAN; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; SUPPORT, NON-U.S. GOV'T; TRANSPLANTATION, HETEROLOGOUS;

EID: 0028819620     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1016/0963-6897(94)00048-O     Document Type: Article

References (78)

1. Behavioral assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway
2. Preliminary report on the use of fetal tissue transplantation to correct MPTP-induced Parkinson-like syndrome in primates
3. Fetal nondopaminergic neural implants in parkinsonian primates: Histochemical and behavioral studies
4. The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism
5. Functional reinnervation of the neurostriatum in the adult rat by use of intraparenchymal grafting of dissociated cell suspensions from the substantia nigra
6. Cross-species neural grafting in a rat model of Parkinson's disease
7. Intracerebral grafting of neuronal cell suspensions I. Introduction and general methods of preparation
8. Intracerebral grafting of neuronal cell suspensions II. Survival and growth of nigral cell suspensions implanted in different brain sites
9. Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers
10. Recovery of dopaminergic fibers in striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse is enhanced by grafts of adrenal medulla
11. Survival and function of dissociated dopamine neurons grafted at different developmental stages or after being cultured in vitro
12. Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival
13. Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons
14. Behavioral effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease
15. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: Immunological aspects, spontaneous and drug-induced behaviour, and dopamine release
16. Intracerebral xenografts of dopamine neurons: The role of immunosuppression and the blood-brain barrier
17. Specific influence of striatal target neurons on the in vitro out-growth of mesencephalic dopaminergic neurites: A morphological quantitative study
18. Glial heterogeneity may define the three-dimensional shape of mouse mesencephalic dopaminergic neurons
19. Nigral transplants in primate models of parkinsonism
20. 30-month results of foetal dopamine cell transplantation into the brains of parkinsonian patients
21. Adrenal medullary autografts into the basal ganglia of Cebus monkeys: Injury induced regeneration
22. Transplantation of embryonic marmoset dopaminergic neurons to the corpus striatum of marmosets rendered parkinsonian by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
23. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 mo after transplantation for Parkinson's disease
24. Restoration of dopaminergic function by grafting of fetal rat substantia nigra to the caudate nucleus: Long-term behavioral, biochemical, and histochemical studies
25. Cross-species grafts of embryonic rabbit mesencephalic tissue survive and cause behavioral recovery in the presence of chronic immunosuppression
26. Fetal transplantation in Parkinson's disease
27. Human cadaver embryonic substantia nigra grafts: Effects of ontogeny, preoperative graft preparation and tissue storage
28. Influence of donor age on the survival of human embryonic dopaminergic neural grafts
29. Development of dopaminergic neurons in the human substantia nigra
30. Cross-species intracerebral grafting of embryonic swine dopaminergic neurons
31. A comparison of solid intraventricular and dissociated intraparenchymal fetal substantia nigra grafts in a rat model in Parkinson's disease: Impaired graft survival is associated with high baseline rotational behavior
32. Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease
33. Correlation of fetal age and measurements between 10 and 26 wk of gestation
34. Survival of TH-positive and neuromelanin-containing cells in patients with Parkinson's disease after intrastriatal grafting of fetal ventral mesencephalon
35. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques
36. Transplant operation of human fetal substantia nigral tissue to caudate nucleus in Parkinson's disease: First clinical trials
37. Transplant operation of human fetal substantia nigral tissue to caudate nucleus in Parkinson's disease: First clinical trials
38. Xenografting of fetal pig ventral mesencephalon corrects motor asymmetry in the rat model of Parkinson's disease
39. Transplantation of embryonic occipital cortex to the brain of newborn rats
40. The rat brain
41. Core assessment for intracerebral transplantations (CAPIT)
42. The time of genesis, embryonic origin and differentiation of the brain stem monoamine neurons in the rhesus monkey
43. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease
44. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease
45. CPH Neural transplantation group. Can an analogy be drawn between the clinical evolution of Parkinson's patients who undergo autoimplantation of adrenal medulla and those of fetal ventral mesencephalon transplant recipients?
46. Fetal homotransplants (ventral mesencephalon and adrenal tissue) to the striatum of parkinsonian subjects
47. Transplantation of human fetal mesencephalic tissue in caudate nucleus as treatment for Parkinson's disease: The Cuban experience
48. Low pressure aspiration abortion for obtaining embryonic and early gestational fetal tissue for research purposes
49. Restoration of complex sensorimotor behavior and skilled forelimb use by a modified nigral cell suspension transplantation approach in the rat Parkinson model
50. Brain tissue transplanted to the anterior chamber of the eye. 1. Fluorescence histochemistry of immature catecholamine and 5-hydroxytryptamine neurons reinnervating the rat iris
51. Human fetal tissues grafted to rodent hosts: Structural and functional observations of brain, adrenal and heart tissues in oculo
52. Developmental stages in human embryos
53. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system
54. Fetal neural graft survival
55. Cryopreservation, culture and transplantation of human fetal mesencephalic tissue into monkeys
56. Fetal neuronal grafts in monkeys given methylphenyltetrahydro-pyridine
57. Reversible changes in the activities and amounts of tyrosine hydroxylase in dopamine neurons of the substantia nigra in response to axonal injury as studied by immunochemical and immunocytochemical methods
58. Transplantation of fetal dopamine neurons in Parkinson's disease: PET (18F)6-L-Fluorodopa studies in two patients with putaminal implants
59. Intracerebral grafting of dissociated CNS tissue suspensions: A new approach for neuronal transplantation to deep brain sites
60. Intracerebral grafting of neuronal cell suspensions III. Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism
61. Dopamine and cholecystokinin immunoreactive neurones in mesencephalic grafts reinnervating the neostriatum: Evidence for selective growth regulation
62. Quantitation of fiber growth in transplanted central monoamine neurons
63. Effects of intraventricular substantia nigra allografts as a function of donor age
64. Survival and growth of fetal catecholamine neurons transplanted into primate brain
65. Fetal dopamine cell survival after transplantation is dramatically improved at a critical donor gestational age in nonhuman primates
66. Fetal dopamine neural grafts: Extended reversal of methylphenyltetrahydorpridine-induced parkinsonism in monkeys
67. Transplantation of fetal dopamine neurons into primate brain reverses MPTP-induced parkinsonism
68. Axotomy-induced neuronal death during development
69. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease
70. Transplantation of central and peripheral monoamine neurons to the adult rat brain: Techniques and conditions for survival
71. Solid neural grafts in intracerebral transplantation cavities
72. Human fetal mesence-phalic tissue grafted to dopamine-denervated striatum of athymic rats: Light- and electron-microscopical histochemistry and in vivo chronoamperometric studies
73. Human fetal substantia nigra grafted to the dopamine-denervated striatum of immunosuppressed rats: Evidence for functional reinnervation
74. Regenerative properties of central monoamine neurons
75. Early evidence of catecholaminergic cell groups in 5-and 6-week-old human embryos using tyrosine hydroxylase and dopamine-B-hydroxylase immunocytochemistry
76. Axotomy-induced differential gene induction in neurons of the locus ceruleus and substantia nigra
77. Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats
78. Bilateral fetal mesencephalic grafting intwo patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine (MPTP)